Log in

Modeling Enterprise Flexibility and Competitiveness for Indian Pharmaceutical Firms: A Qualitative Study

  • Original Research
  • Published:
Global Journal of Flexible Systems Management Aims and scope Submit manuscript

Abstract

In view of the challenges faced by the present day’s volatile, uncertain, complex and ambiguous environment, high level of flexibility is required for the organizations to sustain and stay competitive. Given the dynamic nature of the pharmaceutical industry in India, the need to be flexible is more pronounced. The Indian pharma sector has witnessed tremendous change in the last several years and hence, it is imperative to explore as to how these firms are addressing the critical issue of flexibility and its consequent linkage with their competitiveness by undertaking a qualitative study to structurally model their inter-relationship. In this paper, a detailed conceptual review of flexibility and competitiveness is presented, after which Total Interpretive Structural Modeling (TISM)—a qualitative method is used for the analysis. TISM is an improvised form of Warfield’s structural modeling tool which is used to develop a model using different types of enterprise flexibility and competitiveness for better understanding of the relationship between these factors. The findings of this study will highlight the possible implications for practitioners and researchers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

(Source: Modified from Sushil and Sushil, 2014)

Fig. 3
Fig. 4
Fig. 5
Fig. 6

(Source: Authors own research)

Similar content being viewed by others

References

Download references

Funding

No funding from any source has been received for this research work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohammad Asim.

Ethics declarations

Conflict of interest

All the authors declare that they do not have any conflict of interest.

Ethical Approval

We have used template not questionnaire and the expert’s details have been anonymized.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Appendices

Appendix 1: Profile of the Experts

S. no.

Category of experts

Number (Total -10)

Profile of the experts

1

Academicians/Researchers

4

Include researchers, and professors-who are either specialist in pharmaceutical research

2

Experts from the Industry

6

Experts from industry-especially pharmaceutical firms. Senior Management level employees of organizations like Novartis, GlaxoSmithKline, Sun Pharma, Lupin, Abbott and Cipla have provided the inputs to the template send to them

Total

10

 

Appendix 2: Sample Template for TISM

See Tables 12, 13, 14, and 15

Table 12 Interpretive logic-knowledge base
Table 13 Direct interaction matrix (Binary matrix) (With significant transitive links)
Table 14 Direct interaction matrix (Interpretive matrix)
Table 15 Please indicate your response to the relationship between the various types of Flexibilities and Competitiveness affecting the pharmaceutical firms in India, as given below, by writing ‘Y’ for ‘Yes’ and ‘N’ for ‘No’ and also cite the reason for the same, in brief

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Asim, M., Nasim, S. Modeling Enterprise Flexibility and Competitiveness for Indian Pharmaceutical Firms: A Qualitative Study. Glob J Flex Syst Manag 23, 551–571 (2022). https://doi.org/10.1007/s40171-022-00318-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40171-022-00318-9

Keywords

Navigation